Tesamorelin (4-Pack)
Tesamorelin (4-Pack)
In stock
- Lab Tested for Purity & Quality
- Fast & Secure Shipping
- Manufactured in Canada
Couldn't load pickup availability
Product Details
- Form: Lyophilized peptide
- Net per vial: 10 mg (filled to approximately 104% of label)
- Purity: ≥99% (HPLC-verified)
- Identity: MS-verified (per COA)
- Storage: 2–8 °C, protect from light
- Formula / M.W.: C221H366N72O67S / 5135.9 Da
- CAS: 218949-48-5
What Makes Tesamorelin a Unique Compound
Tesamorelin is a stabilized synthetic analogue of growth hormone-releasing hormone (GHRH), developed to overcome the rapid degradation of the native hormone while maintaining selective activation of the GHRH receptor. This enhanced stability allows researchers to investigate growth hormone axis physiology with greater consistency and reproducibility compared with endogenous GHRH.
Unlike compounds that directly mimic growth hormone or target downstream metabolic pathways, Tesamorelin functions at the level of the GHRH receptor. By stimulating the body's natural growth hormone signalling cascade, researchers are able to examine upstream endocrine regulation and its influence on growth hormone secretion, lipid metabolism, and broader metabolic physiology.
Scientific literature has extensively explored Tesamorelin within metabolic research, particularly in studies involving visceral adipose tissue, body composition, endocrine regulation, and lipid metabolism. Because these biological processes are closely linked to growth hormone physiology, Tesamorelin has become a valuable research tool for investigating endocrine mechanisms that influence metabolic homeostasis.
For Canadian laboratories studying endocrinology and metabolic biology, Tesamorelin provides a well-characterized peptide supported by decades of research into the growth hormone-releasing hormone axis. Its unique upstream mechanism distinguishes it from direct growth hormone analogues and peptide fragments, making it an important compound for investigating hormonal regulation at the receptor level.
Key Benefits
- GHRH Receptor Research — Tesamorelin is widely investigated for its selective activation of the growth hormone-releasing hormone receptor, allowing researchers to study endocrine regulation at the earliest stages of the growth hormone signalling pathway.
- Growth Hormone Axis Studies — Scientific literature examines Tesamorelin for its influence on pulsatile growth hormone release and the physiological mechanisms governing endocrine function.
- Lipid Metabolism Research — Researchers continue to investigate Tesamorelin in studies involving lipid metabolism, visceral adipose tissue, and metabolic regulation.
- Metabolic Physiology — Tesamorelin is frequently included in metabolic research investigating the relationship between endocrine signalling, energy balance, and body composition through activation of the GHRH pathway.
- Comparative Endocrine Research — Because Tesamorelin acts upstream of growth hormone itself, it is commonly used to compare receptor-mediated signalling with direct growth hormone analogues and peptide fragments.
- Endocrine Biology — By providing a stable model of GHRH receptor activation, Tesamorelin has become an important research tool for studying hormonal regulation, metabolic homeostasis, and growth hormone physiology.
Related Research Peptides
Researchers investigating Tesamorelin frequently study it alongside other peptides involved in metabolic physiology, mitochondrial function, and endocrine research. Common companion compounds include:
- Retatrutide — A next-generation metabolic research peptide widely investigated for GLP-1, GIP, and glucagon receptor biology, providing a complementary approach to metabolic research.
- MOTS-c — A mitochondrial-derived peptide studied for cellular metabolism, mitochondrial signalling, and energy regulation, making it a natural companion to Tesamorelin research.
- HGH Fragment 176-191 — A growth hormone-derived peptide fragment commonly investigated in lipid metabolism research and frequently compared with Tesamorelin because of their distinct mechanisms of action.
Frequently Asked Questions
Where can I buy Tesamorelin in Canada for laboratory research?
Diamond Peptides supplies research-grade Tesamorelin exclusively for scientific and laboratory research throughout Canada. Every production batch undergoes High-Performance Liquid Chromatography (HPLC) purity verification, Mass Spectrometry (MS) identity confirmation, and is supported by batch-specific Certificates of Analysis (COAs).
How is Tesamorelin different from HGH Fragment 176-191?
Although both peptides are frequently investigated in metabolic research, they function through different biological mechanisms. Tesamorelin is a growth hormone-releasing hormone (GHRH) analogue that activates the GHRH receptor and stimulates the body's natural growth hormone signalling pathway, whereas HGH Fragment 176-191 is derived from the growth hormone molecule itself and is investigated for its downstream metabolic activity.
Is Tesamorelin naturally occurring?
No. Tesamorelin is a laboratory-developed synthetic analogue of the naturally occurring growth hormone-releasing hormone (GHRH). It incorporates structural modifications that improve stability while preserving selective interaction with the GHRH receptor for research applications.
How are purity and identity verified?
Every production lot is analyzed using High-Performance Liquid Chromatography (HPLC) to verify a purity of at least 99%, while Mass Spectrometry (MS) confirms molecular identity. Batch-specific Certificates of Analysis are provided to support laboratory quality assurance and research documentation.
⚠️ For research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.
